Antiplatelet and anticoagulant therapy in the secondary prevention of ischemic heart disease.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 10685133.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Antiplatelet and anticoagulant medications play a major role in the secondary prevention of ischemic heart disease. Numerous trials have demonstrated their clinical benefits. Newer agents, such as clopidogrel, have challenged aspirin's role as the premier medication for secondary prevention. Much remains to be learned, however, about the merits of these different drug classes, relative to one another and in combination.
Medical subject headings
- Anticoagulants
- Coronary Disease
- Myocardial Infarction
- Platelet Aggregation Inhibitors